GPT Analysis
Empower Your Investments! Unleash the Potential with Smart Stock Analysis!
| Symbol | Company Name | Rating | Recommendation | Evaluation from GPT | Action | Time |
|---|---|---|---|---|---|---|
| VSACW | Vision Sensing Acquisition Corp - Warrants (21/10/2026) | None | None | None | | None |
| VSACW | Vision Sensing Acquisition Corp - Warrants (21/10/2026) | None | None | None | | None |
| VSACW | Vision Sensing Acquisition Corp - Warrants (21/10/2026) | None | None | None | | None |
| VSACW | Vision Sensing Acquisition Corp - Warrants (21/10/2026) | None | None | None | | None |
| VSACU | Vision Sensing Acquisition Corp - Units (1 Ord Class A & 3/4 War) | None | None | None | | None |
| VSACU | Vision Sensing Acquisition Corp - Units (1 Ord Class A & 3/4 War) | None | None | None | | None |
| VSACU | Vision Sensing Acquisition Corp - Units (1 Ord Class A & 3/4 War) | None | None | None | | None |
| VSACU | Vision Sensing Acquisition Corp - Units (1 Ord Class A & 3/4 War) | None | None | None | | None |
| VSAC | Vision Sensing Acquisition Corp - Class A | None | None | None | | None |
| VSAC | Vision Sensing Acquisition Corp - Class A | None | None | None | | None |
| VSAC | Vision Sensing Acquisition Corp - Class A | None | None | None | | None |
| VSAC | Vision Sensing Acquisition Corp - Class A | None | None | None | | None |
| VS | Versus Systems Inc | None | None | None | | None |
| VS | Versus Systems Inc | None | None | None | | None |
| VS | Versus Systems Inc | None | None | None | | None |
| VS | Versus Systems Inc | None | None | None | | None |
| VRTX | Vertex Pharmaceuticals Inc | 90 | Positive | Vertex Pharmaceuticals Inc (VRTX) is a leading biotechnology company specializing in the development of innovative medicines for serious diseases. With a strong track record of successful drug development and a robust pipeline of potential treatments, VRTX has shown promising growth prospects. The stock has consistently performed well, with a year-to-date gain of 28.8% and a solid year-high of $510.64. VRTX has a market cap of $124.33 billion, indicating its dominance in the industry. The stock's 50-day and 200-day moving averages of $473.45 and $446.37, respectively, indicate a | | 2024-10-14 11:12:36 |
| VRTV | Veritiv Corp | None | None | None | | None |
| VRTV | Veritiv Corp | None | None | None | | None |
| VRTV | Veritiv Corp | None | None | None | | None |